Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

US Patent 6660753 · Granted Dec 9, 2003

Estimated economic value: $16,141,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-variable MUC1* antibodies and uses thereof2025
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Agents for differentiating stem cells and treating cancer2025
Methods for deriving dopaminergic neurons from pluripotent stem cells2024
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2024
Method of screening for agents for differentiating stem cells2024
Endoparasitic depsipeptides2023
Endoparasitic depsipeptides2023
(Trifluoromethyl)pyrimidine-2-amine compounds2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023